1989 - 1994年非洲A群脑膜炎奈瑟菌III亚群的流行情况。
Epidemics of serogroup A Neisseria meningitidis of subgroup III in Africa, 1989-94.
作者信息
Guibourdenche M, Høiby E A, Riou J Y, Varaine F, Joguet C, Caugant D A
机构信息
Institut Pasteur, Paris, France.
出版信息
Epidemiol Infect. 1996 Apr;116(2):115-20. doi: 10.1017/s095026880005233x.
Abstract
A total of 125 strains of Neisseria meningitidis recovered in the course of outbreaks from patients with systemic disease in 11 African countries between 1989 and 1994 were analysed by serogrouping, serotyping and multilocus enzyme electrophoresis. Of the 125 patient strains 115 (92%) belonged to the clone-complex of serogroup A meningococci, designated subgroup III. Among the remaining strains, 4 were also serogroup A, but belonged to the clonal groups I and IV-1 (2 strains each), whilst 6 strains (4 serogroup C and 2 serogroup W135) represented clones of the ET-37 complex. Our results indicated that the second pandemic caused by clones of subgroup III is still spreading in Africa. Towards the West it has reached Niger, Mali, Guinea and The Gambia, and towards the South, the Central African Republic, Uganda, Rwanda, Burundi, Tanzania and Zambia.
摘要
对1989年至1994年间在11个非洲国家从患有全身性疾病的患者身上分离出的125株脑膜炎奈瑟菌进行了血清群分类、血清型分型和多位点酶电泳分析。在这125株患者菌株中，115株（92%）属于A群脑膜炎球菌的克隆复合体，称为III亚组。在其余菌株中，4株也是A群，但属于克隆群I和IV-1（各2株），而6株（4株C群和2株W135群）代表ET-37复合体的克隆。我们的结果表明，由III亚组克隆引起的第二次大流行仍在非洲蔓延。向西已蔓延至尼日尔、马里、几内亚和冈比亚，向南已蔓延至中非共和国、乌干达、卢旺达、布隆迪、坦桑尼亚和赞比亚。
相似文献
1
Epidemics of serogroup A Neisseria meningitidis of subgroup III in Africa, 1989-94.1989 - 1994年非洲A群脑膜炎奈瑟菌III亚群的流行情况。
Epidemiol Infect. 1996 Apr;116(2):115-20. doi: 10.1017/s095026880005233x.
2
Meningitis caused by a serogroup W135 clone of the ET-37 complex of Neisseria meningitidis in West Africa.西非由脑膜炎奈瑟菌ET-37复合体的W135血清群克隆株引起的脑膜炎
Trop Med Int Health. 1998 Sep;3(9):742-6. doi: 10.1046/j.1365-3156.1998.00300.x.
3
Characteristics of serogroup A Neisseria meningitidis responsible for an epidemic in Ethiopia, 1988-89.1988 - 1989年埃塞俄比亚A群脑膜炎奈瑟菌流行株的特征
Scand J Infect Dis. 1990;22(2):171-4. doi: 10.3109/00365549009037898.
4
Serogroup A Neisseria meningitidis of clone III-1 present in western Norway as early as 1969-73.早在1969年至1973年，克隆III-1的A群脑膜炎奈瑟菌就出现在挪威西部。
Scand J Infect Dis. 1990;22(2):241-2. doi: 10.3109/00365549009037910.
5
Molecular epidemiology and emergence of worldwide epidemic clones of Neisseria meningitidis in Taiwan.台湾地区脑膜炎奈瑟菌的分子流行病学及全球流行克隆株的出现
BMC Infect Dis. 2006 Feb 15;6:25. doi: 10.1186/1471-2334-6-25.
6
7
A comparison of the variable antigens expressed by clone IV-1 and subgroup III of Neisseria meningitidis serogroup A.A群脑膜炎奈瑟菌IV-1克隆株和III亚组表达的可变抗原比较
J Infect Dis. 1992 Jan;165(1):53-68. doi: 10.1093/infdis/165.1.53.
8
Clonal expansion of sequence type (ST-)5 and emergence of ST-7 in serogroup A meningococci, Africa.非洲A群脑膜炎奈瑟菌中序列型（ST-）5的克隆扩增及ST-7的出现
Emerg Infect Dis. 2001 Sep-Oct;7(5):849-54. doi: 10.3201/eid0705.010513.
9
Characteristics of serogroup A Neisseria meningitidis strains isolated in the Central African Republic in February 1992.1992年2月在中非共和国分离出的A群脑膜炎奈瑟菌菌株的特征
Eur J Clin Microbiol Infect Dis. 1994 Feb;13(2):174-7. doi: 10.1007/BF01982194.
10
Epidemic spread of subgroup III of Neisseria meningitidis serogroup A to South Africa in 1996.1996年，A群脑膜炎奈瑟菌III亚群在南非的流行传播。
Clin Infect Dis. 1998 Nov;27(5):1214-20. doi: 10.1086/514971.
引用本文的文献
1
Challenges and opportunities for meningococcal vaccination in the developing world.发展中国家脑膜炎球菌疫苗接种的挑战与机遇。
Hum Vaccin Immunother. 2018 May 4;14(5):1084-1097. doi: 10.1080/21645515.2018.1434463. Epub 2018 Feb 23.
2
Meningococcal disease and climate.脑膜炎球菌病与气候
Glob Health Action. 2009 Nov 11;2. doi: 10.3402/gha.v2i0.2061.
3
Preparedness for infectious threats: public-private partnership to develop an affordable vaccine for an emergent threat: the trivalent Neisseria meningitidis ACW135 polysaccharide vaccine.针对传染性威胁的防范：公私合作开发针对突发威胁的平价疫苗：三价脑膜炎奈瑟菌ACW135多糖疫苗
Am J Public Health. 2007 Apr;97 Suppl 1(Suppl 1):S15-22. doi: 10.2105/AJPH.2005.075085. Epub 2007 Apr 5.
4
Preparation and characterization of group A meningococcal capsular polysaccharide conjugates and evaluation of their immunogenicity in mice.A群脑膜炎球菌荚膜多糖结合物的制备与表征及其在小鼠体内免疫原性的评估
Infect Immun. 2003 Sep;71(9):5115-20. doi: 10.1128/IAI.71.9.5115-5120.2003.
5
Recent increase in meningitis Caused by Neisseria meningitidis serogroups A and W135, Yaoundé, Cameroon.喀麦隆雅温得，由A群和W135群脑膜炎奈瑟菌引起的脑膜炎近期有所增加。
Emerg Infect Dis. 2002 Mar;8(3):327-9. doi: 10.3201/eid0803.010308.
6
Neisseria meningitidis serogroups W135 and A were equally prevalent among meningitis cases occurring at the end of the 2001 epidemics in Burkina Faso and Niger.在布基纳法索和尼日尔2001年疫情末期发生的脑膜炎病例中，W135群和A群脑膜炎奈瑟菌的流行程度相当。
J Clin Microbiol. 2002 Mar;40(3):1083-4. doi: 10.1128/JCM.40.3.1083-1084.2002.
7
Update on meningococcal disease with emphasis on pathogenesis and clinical management.脑膜炎球菌病最新进展，重点关注发病机制与临床管理。
Clin Microbiol Rev. 2000 Jan;13(1):144-66, table of contents. doi: 10.1128/CMR.13.1.144.
8
Genetic analysis of a meningococcal population based on polymorphism of the pilA-pilB locus: a molecular approach for meningococcal epidemiology.基于pilA-pilB基因座多态性的脑膜炎球菌群体遗传分析：一种脑膜炎球菌流行病学的分子方法
J Clin Microbiol. 1997 Mar;35(3):745-50. doi: 10.1128/jcm.35.3.745-750.1997.
本文引用的文献
1
Antigenic and epidemiologic properties of the ET-37 complex of Neisseria meningitidis.脑膜炎奈瑟菌ET-37复合体的抗原性和流行病学特性。
J Infect Dis. 1993 Jun;167(6):1320-9. doi: 10.1093/infdis/167.6.1320.
2
Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population.随机抽样人群中脑膜炎奈瑟菌的无症状携带情况。
J Clin Microbiol. 1994 Feb;32(2):323-30. doi: 10.1128/jcm.32.2.323-330.1994.
3
Meningococcal meningitis and carriage in western Zaire: a hypoendemic zone related to climate?扎伊尔西部的脑膜炎球菌性脑膜炎与带菌状态：一个与气候相关的低发区？
Epidemiol Infect. 1995 Feb;114(1):75-92. doi: 10.1017/s0950268800051931.
4
Trans-isolate medium: a new medium for primary culturing and transport of Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae.跨膜分离培养基：一种用于脑膜炎奈瑟菌、肺炎链球菌和流感嗜血杆菌原代培养及转运的新型培养基。
J Clin Microbiol. 1984 Jul;20(1):55-8. doi: 10.1128/jcm.20.1.55-58.1984.
5
Meningococcal disease: still with us.脑膜炎球菌病：仍与我们相伴。
Rev Infect Dis. 1983 Jan-Feb;5(1):71-91. doi: 10.1093/clinids/5.1.71.
6
[Transport medium for meningococci].[脑膜炎球菌的转运培养基]
Ann Inst Pasteur (Paris). 1967 Aug;113(2):260-3.
7
Group A meningococcal carriage in travelers returning from Saudi Arabia.从沙特阿拉伯返回的旅行者中A群脑膜炎球菌携带情况。
JAMA. 1988 Nov 11;260(18):2686-9.
8
Clonal population structure of Neisseria meningitidis serogroup A isolated from epidemics and pandemics between 1915 and 1983.1915年至1983年间从流行性和大流行性疫情中分离出的A群脑膜炎奈瑟菌的克隆群体结构。
Rev Infect Dis. 1987 Jul-Aug;9(4):665-92. doi: 10.1093/clinids/9.4.665.
9
Intercontinental spread of an epidemic group A Neisseria meningitidis strain.流行性A群脑膜炎奈瑟菌菌株的洲际传播
Lancet. 1989 Jul 29;2(8657):260-3. doi: 10.1016/s0140-6736(89)90439-x.
10
Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics.用于细菌群体遗传学和系统学的多位点酶电泳方法。
Appl Environ Microbiol. 1986 May;51(5):873-84. doi: 10.1128/aem.51.5.873-884.1986.
Zotero 插件